Clover May

Clover is an associate in the Emerging Companies and M&A team in London. She specialises in advising companies and investors in the technology and life science sectors on venture capital investments, M&A transactions and general corporate matters.

最新新闻和观点

View Clover's insights

点击此处了解更多

酒店与休闲

Advising on Tropic Biosciences' US$105 million Series C financing

2026年3月25日

作者

就业、养老金和流动性

New legislation governing Allocation of Tips to come into force in July 2024

2024年3月21日

Quick read

作者 Clover May

点击此处了解更多

员工激励

Lexology Executive Compensation & Employee Benefits 2023 - UK chapter

2023年11月14日

作者

点击此处了解更多

Clover May

专长

执业领域和服务团队

行业

最新新闻和观点

Advising on Tropic Biosciences' US$105 million Series C financing

Clover May

专长

执业领域和服务团队

行业

最新新闻和观点

Advising on Tropic Biosciences' US$105 million Series C financing

Related news & insights

Taylor Wessing strengthens Corporate/M&A practice with Equity Partner Jan Hückel

Carbon Border Adjustment Mechanism (CBAM): From Reporting to Real Financial Impact

Request for a Preliminary Ruling by Federal Court of Justice on the Prohibition of Advertising for Remote Medical Treatments under Section 9 HWG

Sustainability Stories: Notpla

EU Inc. – The 28th Regime: How the European Commission intends to revolutionise the formation of companies

Consumer and Retail in the News

Prediction Markets in Germany and Europe: Legal Status, Risks, and Opportunities

Investing in the German Audit and Tax Advisory Market – Opportunity Amid Regulatory Debate

More Than Share and Asset Deals: Innovative Transaction Structures for MedTech Companies

German Special Fund for Infrastructure and Climate Neutrality

相关人员

与我会面：